Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

Denver TMAU Test Lab survey click here
click to Read more/less

USA survey for anyone who wants to improve Denver TMAU test

begun : Dec22
end : no ending for now

A trainee genetic counselor is working at the Denver TMAU test lab. Probably as part of her training. As a project she wishes feedback on any aspect of the Denver TMAU test and process. You can fill in the survey and/or email her (email address is in survey). It's meant for USA people, but perhaps others can give their view too (as we have so few opportunities).

quote from her rareconnect post

"Hello all! I wanted to make you aware of a research study being conducted to better understand the experience and needs of individuals with trimethylaminuria with a goal of being able to create improved patient and healthcare provider education materials. Any participation is completely voluntary and all responses remain confidential. Feel free to use the contact information within the link with any questions or share the survey with others with TMAU."

see this post for more details

Wednesday, November 2, 2011

TEN Body Odor Questions on "Nutritional metabolic and endocrine disorders > TMAU" published in UK NHS Database

BREAKING NEWS : On October 21, 2011, ten (10) body odor related uncertainties / questions have been published in the October report to the UK National Institutes for Health Research (NIHR) Database, under the category of ‘Nutritional metabolic and endocrine disorders > Trimethylaminuria’(see left column).

The benefit of the publication of these that they have been identified and made explicit by the authorities in an attempt to address and “prioritise new research” of the questions/uncertainties published.
These questions can be seen in the Library of NHS UK, Database of Uncertainties about the Effects of Treatments (UK DUETs).
Six (6) of these listed uncertainties have referenced their source to MEBO Research (see, "View Details of each question"), and four (4) of them reference the source to the DUETs Editorial Team.
The benefit of this publication by the Special Health Authority established by order of the Secretary of State for Health, is that these questions have been identified and made explicit by the authorities in an attempt to address and “prioritise new research” of the questions/uncertainties published. With this validation, it is hoped that research grants would be more readily obtained from government and private sources to study these uncertainties.

The following questions are the nine (9) uncertainties 'From patients' and one (1) 'From professionals' published in this NHS Evidence website of the National Institute for Health and Clinical Excellence (NICE).

From Professionals: (Click on 'View Details') Is there a bacteria responsible for producing trimethylamine (TMA) in the gut?

From Patients: (Click on 'View Details' of each question)
  1. Do high plasma levels of trimethylamine (TMAO) gut flora metabolism of phosphatidylcholine cause cardiovascular disease?
  2. In-vitro screening to test whether ataluren (PTC124) can correct functional consequences of premature termination mutations of the Flavin containing monooxygenase 3 (FMO3) gene?
  3. To what extent are individuals with trimethylaminuria, and lack functional hepatic flavin containing monooxygenase 3 (FMO3) substrates, unable to oxidize other odiferous FMO3-specific substrates and does this contribute significantly to body odour?
  4. Which bacterial species in the human intestine are responsible for the generation of trimethylamine?
  5. Would a comprehensive biochemical screening test for trimethylaminuria help patients?
  6. Do probiotics significantly reduce trimethylaminuria (TMAU1) producing bacteria in the human intestine and does this result in clinically relevant decreases in TMA production, and thus body odour, in patients with TMAU1?
  7. Enzyme replacement therapy for trimethylaminuria (odour problems)
  8. How effective are antibiotics for trimethylaminuria?
  9. How effective is a choline elimination diet for treating trimethylaminuria?

HOW DID THIS COME ABOUT? On March 2011, our very own, Karen James, launched a campaign, and using her own words in a post she wrote for this blog, “…to contact the main British medical organisations and health politicians and appeal to their humanity through persuasive letters, e-mails, and follow-up phone calls.” Sufferers from not only the UK, but from other countries, joined in and sent their emails/mails on targeted dates set up by Karen to present testimonials to these authorities. Eventually, Karen put me in contact with Mark Fenton, UK Database of Uncertainties about the Effects of Treatments (UK DUETs), Project Manager, NHS Evidence, National Institute for Health and Clinical Excellence.

By July 2011, Karen was already raising awareness on a high-profile TV show in an 8-minute interview, as the wheels in the British General Medical Council (GMC) and other agencies were turning; and eventually, she was referred to Mark Fenton, Project Manager of UK DUETs. She and I began to work with Mark with the help of an expert in FMO3 in the UK to create a list of questions or uncertainties to be published in the UK National Institute for Health and Clinical Excellence (NICE), DUETs. Researchers are welcome to make reference to these question if they wish to apply for government or private research grants to them.

Our most sincere gratitude goes to Karen James for having initiated and followed through on this endeavor. Without her taking these measures, this would never have come to fruition. This is a perfect example of how one person can make a difference.


Since as far back as the early to mid 1990s, when a woman told her story in a British documentary about her bromhidrosis and hyperhidrosis, and in 1999, when Alice Mata wrote her book, When Bathing is Not Enough, sufferers have attempted bear testimonials to tell the world of the tribulations a sufferer of body odor encounters on a daily basis in hopes of raising awareness and thus initiating change. Other sufferers have told their stories in books such as, Shattered, The Foul Body Odor that Almost Killed Me, and an Anthology, OUR JOURNEY: OVERCOMING THE STIGMA OF THE INVISIBLE MONSTER, and in televised programs and YouTube videos, such as those referenced in this blog under keyword, Testimonial/Evidence.

Other aspects of our international community’s efforts to raise awareness involves email/mail campaigns to targeted government agencies and the medical community. These projects have included the Raising Awareness in the Mental Health Community regarding the Olfactory Reference Syndrome (ORS) diagnosis, and MEBO's Technical Consultant designing flyers to be printed by sufferers throughout the world and left at strategic places, like libraries, schools, doctor’s office, hospitals, etc. Each and every sufferer is encouraged to attempt to communicate with his or her physician by providing the physician with published literature on body odor conditions. These are only some ways to raise awareness of Body Odor Conditions in the medical community, and sufferers are encouraged to "think outside the box" to come up with many more.


María de la Torre
Founder and Executive Director

A Public Charity
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)

SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.

Please use your credit card to make your donation to MEBO.

Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner

A EURORDIS and NORD Member Organization


Post a Comment